Bibliographic Details
| Title: |
177Lu-PSMA SPECT Quantitation at 6 Weeks (Dose 2) Predicts Short Progression-Free Survival for Patients Undergoing 177Lu-PSMA-I&T Therapy. |
| Authors: |
John, Nikeith1,2, Pathmanandavel, Sarennya1, Crumbaker, Megan2,3,4, Counter, William1, Bao Ho1, Yam, Andrew O.2,3,4, Wilson, Peter5, Niman, Remy5, Ayers, Maria1, Poole, Aron1, Hickey, Adam1, Agrawal, Shikha1, Perkins, Gary1, Kallinen, Annukka1, Eslick, Enid1, Stockler, Martin R.6, Joshua, Anthony M.2,3,4, Nguyen, Andrew1,2, Emmett, Louise1,2,3 louise.emmett@svha.org.au |
| Source: |
Journal of Nuclear Medicine. Mar2023, Vol. 64 Issue 3, p410-415. 6p. |
| Database: |
Engineering Source |
